FDA pharmacologic class
Androgen Receptor Inhibitor
5 medicines are in FDA's class of androgen receptor inhibitors: bicalutamide (Casodex), enzalutamide (Xtandi), flutamide (Eulexin), clascoterone (Winlevi) and nilutamide. 3 of the 5 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is bicalutamide 50 mg tablet at $0.404 per tablet (NADAC).
Which medicines are androgen receptor inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Bicalutamide | Casodex | 6 labelers | $0.404 per tablet 50 mg tablet | No | No current entry | 0 |
| Enzalutamide | Xtandi | none listed | n/a | No | No current entry | 0 |
| Flutamide | Eulexin | 1 labeler | n/a | Yes | No current entry | 0 |
| Clascoterone | Winlevi | none listed | $10.00 per gram 1% cream | No | No current entry | 0 |
| Nilutamide | none listed | 1 labeler | n/a | Yes | A presentation being discontinued | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price